相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study
Pascal Benkert et al.
LANCET NEUROLOGY (2022)
Plasma neurofilament light chain concentrations as a biomarker of clinical and radiologic outcomes in relapsing multiple sclerosis: Post hoc analysis of Phase 3 ozanimod trials
Sarah Harris et al.
EUROPEAN JOURNAL OF NEUROLOGY (2021)
The effect of sex on multiple sclerosis risk and disease progression
Rhonda R. Voskuhl
MULTIPLE SCLEROSIS JOURNAL (2020)
Selective Estrogen Receptor Modulators Enhance CNS Remyelination Independent of Estrogen Receptors
Kelsey A. Rankin et al.
JOURNAL OF NEUROSCIENCE (2019)
Gene expression in oligodendrocytes during remyelination reveals cholesterol homeostasis as a therapeutic target in multiple sclerosis
Rhonda R. Voskuhl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
Christian Barro et al.
BRAIN (2018)
Estrogen Interactions With Lipid Rafts Related to Neuroprotection. Impact of Brain Ageing and Menopause
Raquel Marin et al.
FRONTIERS IN NEUROSCIENCE (2018)
Estriol-mediated neuroprotection in multiple sclerosis localized by voxel-based morphometry
Allan MacKenzie-Graham et al.
BRAIN AND BEHAVIOR (2018)
Oestrogen receptor β ligand acts on CD11c+ cells to mediate protection in experimental autoimmune encephalomyelitis
Roy Y. Kim et al.
BRAIN (2018)
Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury
E. B. Engler-Chiurazzi et al.
PROGRESS IN NEUROBIOLOGY (2017)
Role of Estrogen and Other Sex Hormones in Brain Aging. Neuroprotection and DNA Repair
Sandra Zarate et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
Serum Neurofilament Light: A Biomarker of Neuronal Damage in Multiple Sclerosis
Giulio Disanto et al.
ANNALS OF NEUROLOGY (2017)
Predictors of Long-Term Disability Accrual in Relapse-Onset Multiple Sclerosis
Vilija G. Jokubaitis et al.
ANNALS OF NEUROLOGY (2016)
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial
Rhonda R. Voskuhl et al.
LANCET NEUROLOGY (2016)
Estrogen receptor (ER) expression in oligodendrocytes is required for attenuation of clinical disease by an ER ligand
A. J. Khalaj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERα)
Stefan M. Gold et al.
LABORATORY INVESTIGATION (2009)
Differential neuroprotective and anti inflammatory effects of estrogen receptor (ER)α and ERβ ligand treatment
Seema Tiwari-Woodruff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol
SS Soldan et al.
JOURNAL OF IMMUNOLOGY (2003)
Treatment of multiple sclerosis with the pregnancy hormone estriol
NL Sicotte et al.
ANNALS OF NEUROLOGY (2002)
分享论文
